Krystal Biotech, Inc(NASDAQ:KRYS) 
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullo...
Website: http://www.krystalbio.com
Founded: 2015
Full Time Employees: 51
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 170.91
H 173.99
L 166.89
C 171.30
V 444,673
10EMA 171.30
20EMA 171.30
60EMA 171.30
120EMA 171.30
250EMA 171.30